Search results

Congress marks watershed moment for nuclear medicine and ANSTO

ANSTO is working with academic and industry partners on the development of multiscale numerical simulations of Laser Metal Deposition (LMD) 3D printing.

See details of previously published customer updates from our Health products team. 

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

ANSTO has put together a robust multidisciplinary approach to understanding the impacts of nanomaterials, investigating a common food additive, E171 titanium dioxide, used primarily as a colouring agent in everyday foods. 

Project Bright, the construction of eight new beamlines at ANSTO’s Australian Synchrotron has reached a milestone by achieving ‘First Light’ for the new micro-computed tomography (MCT) beamline in late NovembeR.

Study explored how key proteins manage dietary cholesterol absorption and elucidated crucial transport mechanisms that contribute to cholesterol balance in the body.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

The ANSTO Science Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.

Specifications, Beryllium Filter, User Manual, Instrument reference

ANSTO is contributing to key critical minerals projects funded by the Federal Government.